NCT07627074 — "Weight Loss in Adults Using Semaglutide (Real-world Study)" trial site landscape

Public-registry site landscape for NCT07627074, “Weight Loss in Adults Using Semaglutide (Real-world Study)”, a Overweight study sponsored by Novo Nordisk A/S. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07627074 (registry record)
Study title	Weight Loss in Adults Using Semaglutide (Real-world Study)
Official title	Real-world Weight Outcomes in Adults Treated With Semaglutide s.c. 1.0 mg or 1.7 mg for Weight Management: a Non-interventional Cohort Study
Sponsor	Novo Nordisk A/S
Condition(s)	Overweight; Obesity
Phase	—
Listed sites	2
Site countries	United States, United Kingdom

Patient-friendly overview of this study: eichor.com/study/NCT07627074.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07627074 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Overweight trials

More from Novo Nordisk A/S

← Eichor home · All tracked trials · Overweight studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →